1. Home
  2. AEYE vs ONCY Comparison

AEYE vs ONCY Comparison

Compare AEYE & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioEye Inc.

AEYE

AudioEye Inc.

SELL

Current Price

$6.66

Market Cap

86.2M

Sector

Technology

ML Signal

SELL

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.50

Market Cap

80.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEYE
ONCY
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
86.2M
80.5M
IPO Year
2011
2002

Fundamental Metrics

Financial Performance
Metric
AEYE
ONCY
Price
$6.66
$0.50
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
★ $17.33
$4.16
AVG Volume (30 Days)
63.8K
★ 1.3M
Earning Date
11-03-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 30.56
N/A
EPS
N/A
★ N/A
Revenue
★ $40,311,000.00
N/A
Revenue This Year
$8.25
N/A
Revenue Next Year
$10.24
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.52
N/A
52 Week Low
$5.31
$0.44
52 Week High
$16.39
$1.32

Technical Indicators

Market Signals
Indicator
AEYE
ONCY
Relative Strength Index (RSI) 43.11 29.93
Support Level $6.61 N/A
Resistance Level $7.32 $0.89
Average True Range (ATR) 0.31 0.06
MACD -0.01 -0.01
Stochastic Oscillator 9.76 24.48

Price Performance

Historical Comparison
AEYE
ONCY

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences. It generates revenue through the sale of subscriptions for software-as-a-service (SaaS). accessibility solutions.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: